Jiecheng Zhang

Statistics

Publications

Citations

623

H-Index

Active since

2018

Affiliations

Institute of Hematology & Blood Diseases Hospital(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

Fujian Medical University

Union Hospital

Beijing Tongren Hospital

Jiecheng Zhang is an author at Institute of Hematology & Blood Diseases Hospital specializing in life sciences, chimeric antigen receptor t-cell therapy, and immunotherapy.

ORCID

Publications per year

2018–2024

Publications

Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial

Jing Pan, Yue Tan, Guoling Wang et al. · Journal of Clinical Oncology · 2021 · 294 citations

Life Sciences, Hematology, Immunology +15

Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia

Yue Tan, Lingling Shan, Liping Zhao et al. · Journal of Hematology & Oncology · 2023 · 84 citations · Full text

Life Sciences, Hematology, Immunology +17

Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study

Jing Pan, Kaiting Tang, Yuechen Luo et al. · The Lancet Oncology · 2023 · 65 citations

Life Sciences, Hematology, Oncology +16

Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial

Jing Pan, Yue Tan, Lingling Shan et al. · Nature Medicine · 2024 · 45 citations

Life Sciences, Immunology, Oncology +15

<p>KRT17 Functions as a Tumor Promoter and Regulates Proliferation, Migration and Invasion in Pancreatic Cancer via mTOR/S6k1 Pathway</p>

Ding Li, Xiaofeng Ni, Hengjie Tang et al. · Cancer Management and Research · 2020 · 40 citations · Full text

Medicine, Molecular Biology, Oncology +17

1–5 of 9